Cargando…
Disease-modifying anti-rheumatic drugs for the management of Takayasu arteritis—a systematic review and meta-analysis
The pharmacotherapy of Takayasu arteritis (TAK) with disease-modifying anti-rheumatic drugs (DMARDs) is an evolving area. A systematic review of Scopus, Web of Science, Pubmed Central, clinical trial databases and recent international rheumatology conferences for interventional and observational stu...
Autores principales: | Misra, Durga Prasanna, Rathore, Upendra, Patro, Pallavi, Agarwal, Vikas, Sharma, Aman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087890/ https://www.ncbi.nlm.nih.gov/pubmed/33932173 http://dx.doi.org/10.1007/s10067-021-05743-2 |
Ejemplares similares
-
Patient-Reported Outcome Measures in Takayasu Arteritis: A Systematic Review and Meta-Analysis
por: Misra, Durga P., et al.
Publicado: (2021) -
Arterial wall fibrosis in Takayasu arteritis and its potential for therapeutic modulation
por: Misra, Durga Prasanna, et al.
Publicado: (2023) -
Outcome Measures and Biomarkers for Disease Assessment in Takayasu Arteritis
por: Misra, Durga Prasanna, et al.
Publicado: (2022) -
Comparison of Presentation and Prognosis of Takayasu Arteritis with or without Stroke or Transient Ischemic Attack—A Retrospective Cohort Study
por: Misra, Durga Prasanna, et al.
Publicado: (2022) -
Impact of Geographic Location on Diagnosis and Initial Management of Takayasu Arteritis: A Tale of Two Cohorts from Italy and India
por: Misra, Durga Prasanna, et al.
Publicado: (2022)